Skip to main content
Medivir logo

Medivir — Investor Relations & Filings

Ticker · MVIR ISIN · SE0020181014 LEI · 549300VWDGUX0WMJ1T79 ST Manufacturing
Open in API
Filings indexed 965 across all filing types
Latest filing 2026-02-05 Capital/Financing Update
Country SE Sweden
Listing ST MVIR

About Medivir

https://www.medivir.com/

Medivir is a pharmaceutical company specializing in the discovery and clinical development of innovative drugs for cancer. The company focuses on oncology areas with high unmet medical needs, aiming to provide transformative treatments for patients with limited therapeutic options. Its research and development strategy is based on extensive expertise in drug design, particularly targeting enzymes such as proteases and polymerases, and includes the use of a proprietary prodrug platform. Medivir actively pursues collaborations with academic and industrial partners to advance its pipeline from research through to commercialization.

Recent filings

Filing Released Lang Actions
Medivir genomför Riktad Nyemission om 45 MSEK till Carl Bennet AB
Capital/Financing Update Classification · 100% confidence The document is a formal announcement by Medivir AB regarding a 'Riktad Nyemission' (Directed Share Issue) of 45 million SEK to Carl Bennet AB. It details the purpose of the capital raise, the dilution effect, the subscription price, and the strategic rationale. This falls squarely under the definition of a capital/financing update, as it describes a specific transaction involving the issuance of new shares to raise capital.
2026-02-05 Swedish
Medivir carries out a directed share issue of SEK 45 million to Carl Bennet AB
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Medivir AB regarding a 'directed share issue' of 90 million new shares to Carl Bennet AB. It details the background, motive, terms, dilution effects, and legal advisors for this capital raise. This falls squarely under the definition of a 'Share Issue/Capital Change' (SHA) as it describes the issuance of new shares to raise capital, rather than a general regulatory filing or a report publication announcement.
2026-02-05 English
Medivirs valberedning utsedd inför årsstämman 2026
AGM Information Classification · 95% confidence The document is a short announcement regarding the appointment of a nomination committee (valberedning) for the upcoming 2026 Annual General Meeting. It lists the members of the committee and the date of the meeting. This type of corporate governance announcement, which precedes the actual meeting materials, is best classified as a general regulatory filing or governance-related announcement. Given the specific categories, 'RNS' (Regulatory Filings) is the most appropriate fallback for this type of corporate governance notification.
2026-01-28 Swedish
Nomination Committee of Medivir appointed
AGM Information Classification · 98% confidence The document announces the appointment of a Nomination Committee for the upcoming Annual General Meeting. It lists the members of the committee and provides the date for the 2026 AGM. This type of announcement regarding board-related committee appointments and meeting preparations falls under general regulatory announcements as it does not constitute a full proxy statement, a voting result, or a specific management change announcement.
2026-01-28 English
BULLETIN FROM EXTRAORDINARY GENERAL MEETING in MEDIVIR AB (PUBL)
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a bulletin from an Extraordinary General Meeting (EGM) detailing the resolutions adopted, specifically regarding the election of board members and board remuneration. While it mentions the meeting took place, it serves as the official announcement of the voting results and decisions made at that meeting. According to the filing definitions, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the appropriate category for official results from shareholder votes at any general meeting.
2026-01-14 English
KOMMUNIKÉ FRÅN EXTRA BOLAGSSTÄMMA I MEDIVIR AB (PUBL)
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a 'Kommuniké' (communiqué) from an Extraordinary General Meeting (Extra bolagsstämma) of Medivir AB. It details the results of the meeting, specifically the election of board members and decisions regarding board remuneration. Since it reports the official outcomes of shareholder voting and board appointments at a general meeting, it falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2026-01-14 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.